A Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)
A Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)
Recruiting · NCT07700056 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO) | Chronic Pruritus of Unknown Origin | Recruiting | Phase 3 | 2026-09-28 | NCT07700056 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Aeroallergy Research Laboratories | Savannah | United States | 4 |
| Austin Inst for Clinical Research | Pflugerville | United States | 4 |
| Dawes Fretzin Clinical Rea Group | Indianapolis | United States | 6 |
| Driven Research | Miami | United States | 2 |
| Equity Medical | The Bronx | United States | 6 |
| National Allergy and Asthma Research LLS | North Charleston | United States | 5 |
| Optima Research-Boardman | Boardman | United States | 2 |